Lance Berman's Net Worth
$4.31 Million
Who is Lance Berman?
Lance Berman has an estimated net worth of $4.31 Million. This is based on reported shares across multiple companies, which include Relypsa Inc, and CPEX Pharmaceuticals, Inc..
SEC CIK
Lance Berman's CIK is 0001455189
Past Insider Trading and Trends
2014 was Lance Berman's most active year for acquiring shares with 19 total transactions. Lance Berman's most active month to acquire stocks was the month of October. 2014 was Lance Berman's most active year for disposing of shares, totalling 28 transactions. Lance Berman's most active month to dispose stocks was the month of August. 2009 saw Lance Berman paying a total of $317,025.00 for 59,958 shares, this is the most they've acquired in one year. In 2015 Lance Berman cashed out on 72,210 shares for a total of $1,124,060.12, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Relypsa Inc No price found
Chief Medical Officer and SVPLance Berman used to own units in Common Stock but no longer holds any shares there.acquired a total of 169,000 shares in Relypsa Inc at a cost of $619,940.16, Lance also disposed a total of 169,000 shares of Relypsa Inc equalling to $4,574,981.93.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -21.11K |
$32.00 | -$808,864.00 |
0
|
Sep 1
| |||
Form 4
| -6.55% | -1.48K |
$31.89 | -$47,197.20 | 21.11K |
Aug 15
| |||
Form 4
| +6.11% | 1.3K |
$19.96 | -$15,628.68 | 22.59K |
Jun 3
| |||
Form 4
|
—
|
0
|
$17.18 | -$774,817.80 | 21.29K |
Scheduled
|
Dec 7 - Dec 9
| ||
Form 4
| +41.56% | 6.25K |
—
|
—
| 21.29K |
Nov 6
| |||
Form 4
| -4.51% | -710.00 |
$24.77 | -$17,586.20 | 15.04K |
Aug 17
| |||
Form 4
| +110.00% | 8.25K |
—
|
—
| 15.75K |
Aug 10
| |||
Form 4
|
—
|
0
|
$21.71 | -$164,819.32 | 7.5K |
Scheduled
|
Feb 24
| ||
Form 4
|
—
|
0
|
$14.75 | -$102,496.16 | 7.5K |
Scheduled
|
Nov 28
| ||
Form 4
|
—
|
0
|
$14.63 | -$622,200.96 | 7.5K |
Scheduled
|
Nov 24 - Nov 25
| ||
Form 4
|
—
|
0
|
$13.21 | -$87,967.44 | 7.5K |
Scheduled
|
Sep 24
| ||
Form 4
|
—
|
0
|
$15.51 | -$415,153.58 | 7.5K |
Scheduled
|
Aug 22 - Aug 25
| ||
Form 4
|
∞
| 7.5K |
—
|
—
| 7.5K |
Aug 14
| |||
Form 4
|
—
|
0
|
$13.94 | -$898,310.43 |
0
|
Scheduled
|
Jul 22 - Jul 24
| ||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CPEX Pharmaceuticals, Inc. No price found
Chief Medical OfficerLance Berman used to own units in Common Stock but no longer holds any shares there.acquired a total of 48,306 shares in CPEX Pharmaceuticals, Inc., Lance also disposed a total of 62,100 shares of CPEX Pharmaceuticals, Inc. equalling to $350,080.75.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -13.79K |
$27.25 |
—
|
0
|
Apr 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||